---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-029531"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2025-09-19T23:59:59+00:00"
generated_at: "2026-05-17T06:07:34.366479+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Reviva prices $9M public offering of 27M shares and warrants at $0.335/unit

## Summary
- 27M shares of common stock plus Series E (5-year term) and Series F (1-year term) warrants, each exercisable for 27M shares at $0.335.
- Gross proceeds of $9M; net proceeds ~$8.1M after fees and expenses.
- Offering expected to close on or about September 22, 2025, subject to customary conditions.
- Proceeds to fund R&D activities and for working capital and general corporate purposes.
- Placement agent: A.G.P./Alliance Global Partners; securities offered under effective shelf registration statement.

## SEC filing metadata
- accession: 0001437749-25-029531
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2025-09-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774925029531/0001437749-25-029531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925029531/rvph20250919_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-029531
- JSON: https://secwatch.observer/filing/0001437749-25-029531.json
- Plain text: https://secwatch.observer/filing/0001437749-25-029531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.